4.2 Article

A companion to the preclinical common data elements and case report forms for neuropathology studies in epilepsy research. A report of the TASK3 WG2 Neuropathology Working Group of the ILAE/AES Joint Translational Task Force

期刊

EPILEPSIA OPEN
卷 -, 期 -, 页码 -

出版社

WILEY
DOI: 10.1002/epi4.12638

关键词

common data elements; epilepsy; inflammation model; neuropathology; preclinical; rodent

资金

  1. AES
  2. ILAE
  3. Austrian Science Funds [P 26680, P 31777]
  4. National Institutes of Health and Department of Defense, USA
  5. National Institute of Child Health and Human Development [R01HD090884]
  6. EpiEpiNet H2020 [Widespread-2020-5]
  7. Ministry for Science and Research, Germany [16GW0182, 01DN20001]
  8. European Union [722053]

向作者/读者索取更多资源

This study discusses the importance of common data elements for preclinical epilepsy research and addresses neuropathological changes associated with seizures and epilepsy in rodent models. Detailed tables and case report forms are provided to aid in standardization and comparability of translational preclinical epilepsy research.
The International League Against Epilepsy/American Epilepsy Society (ILAE/AES) Joint Translational Task Force initiated the TASK3 working group to create common data elements (CDEs) for various aspects of preclinical epilepsy research studies, which could help improve the standardization of experimental designs. This article addresses neuropathological changes associated with seizures and epilepsy in rodent models of epilepsy. We discuss CDEs for histopathological parameters for neurodegeneration, changes in astrocyte morphology and function, mechanisms of inflammation, and changes in the blood-brain barrier and myelin/oligodendrocytes resulting from recurrent seizures in rats and mice. We provide detailed CDE tables and case report forms (CRFs), and with this companion manuscript, we discuss the rationale and methodological aspects of individual neuropathological examinations. The CDEs, CRFs, and companion paper are available to all researchers, and their use will benefit the harmonization and comparability of translational preclinical epilepsy research. The ultimate hope is to facilitate the development of rational therapy concepts for treating epilepsies, seizures, and comorbidities and the development of biomarkers assessing the pathological state of the disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据